Viewing Study NCT00281658


Ignite Creation Date: 2025-12-25 @ 12:14 AM
Ignite Modification Date: 2026-01-24 @ 5:44 PM
Study NCT ID: NCT00281658
Status: COMPLETED
Last Update Posted: 2023-02-10
First Post: 2006-01-23
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study In Women And Men With Metastatic Breast Cancer That Have Overexpression Of ErbB2
Sponsor: Novartis Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neoplasms, Breast View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ErbB2 positive View
None human epidermal growth factor receptor 2 positive (Her2+) View
None metastatic breast cancer View
None Fluorescence in situ hybridization (FISH) positive View
None Stage IV View